Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study

BACKGROUND: Luteinizing hormone-releasing hormone (LHRH)-agonists in prostate cancer (PCa) patients induce sarcopenic obesity. The effect of LHRH-antagonist on body composition has never been explored. We evaluated changes in fat (FBM) and lean body mass (LBM) in PCa patients undergoing Degarelix. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Palumbo, Carlotta, Antonelli, Alessandro, Triggiani, Luca, Dalla Volta, Alberto, Maffezzoni, Filippo, Zamboni, Stefania, Borghetti, Paolo, Rinaudo, Luca, Valcamonico, Francesca, Maroldi, Roberto, Magrini, Stefano Maria, Simeone, Claudio, Berruti, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958940/
https://www.ncbi.nlm.nih.gov/pubmed/33723362
http://dx.doi.org/10.1038/s41391-021-00345-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958940/
https://www.ncbi.nlm.nih.gov/pubmed/33723362
http://dx.doi.org/10.1038/s41391-021-00345-0

Ejemplares similares